Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Teng-Wen Tsai"'
Publikováno v:
ACS Omega, Vol 6, Iss 8, Pp 5138-5145 (2021)
Externí odkaz:
https://doaj.org/article/b76b6de81e0c4003aa30520b3c2323b9
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248942 (2021)
Peripheral neuropathy (PN) is a dose-limiting, painful adverse reaction associated with the use of paclitaxel. This common side effect was often partially attributed to the solvent used for solubilization of the highly hydrophobic drug substance. The
Externí odkaz:
https://doaj.org/article/d6a5290d518f4b7da2bcb595178a1483
Publikováno v:
Journal of Food and Drug Analysis. 29:717-725
The Rare Disease and Orphan Drug Act (the Act) was enacted in 2000 in Taiwan for the facilitation of the research, development, and accessibility of orphan drugs and special nutritional foods; for the prevention and early diagnosis of rare diseases;
Publikováno v:
ACS Omega, Vol 6, Iss 8, Pp 5138-5145 (2021)
ACS Omega
ACS Omega
The pharmacokinetics, safety, and anticancer efficacy profiles of nanoparticle albumin-bound (nab)-paclitaxel formulations are superior to those of solvent-based paclitaxel formulations. The aims of the present study were to study the effects of nab-
Autor:
Ning-Chun Hsiang1, Weng-Foung Huang2, Churn-Shiouh Gau1, Teng-Wen Tsai1, Lin-Chau Chang1 linchauchang@ntu.edu.tw
Publikováno v:
Journal of Food & Drug Analysis. 2022, Vol. 30 Issue 2, following p282-282. 1p.